D. Damianovich

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

C. Print, C. Blenkiron, S. Grimmond, 2018, npj Genomic Medicine.

Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis

M. Adena, N. Tebbutt, D. Damianovich, 2007, British Journal of Cancer.

A case of cardiogenic shock caused by capecitabine treatment

H. White, D. Damianovich, A. To, 2008, Nature Clinical Practice Cardiovascular Medicine.

Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability

M. McKeage, M. Findlay, A. Hill, 2010, BMC Cancer.

Role of novel targeted agents in the treatment of metastatic colorectal cancer

N. Tebbutt, D. Damianovich, 2007 .

Platinum-specific detection and quantification of oxaliplatin and Pt(R,R-diaminocyclohexane)Cl2 in the blood plasma of colorectal cancer patients

M. McKeage, M. Findlay, D. Damianovich, 2008 .

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

C. Print, C. Blenkiron, S. Grimmond, 2017, bioRxiv.